Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue
Total Revenue	$ 4,960,711	$ 990,199	$ 12,173,964	$ 21,070,983
Operating Expenses
Cost of Sales	2,949,824	581,059	8,438,149	13,008,833
General and Administrative	2,215,109	2,486,044	8,264,098	7,119,288
Impairment of Note Receivable, Goodwill, Equipment and Investment	759,559		1,511,481
Total Operating Expenses	5,924,492	3,067,103	18,213,728	20,128,121
(Loss) Income from Operations	(963,781)	(2,076,904)	(6,039,764)	942,862
Other Income (Expense)
Interest Expense	(9,546)		(111,558)
Foreign Exchange Transaction (Loss) Gain	(3,673,699)	198,817	(1,634,713)	561,345
Realized Loss on Securities Investment	(334,531)	(602,624)	(679,204)	(11,291,166)
Loss on Equity Method Investment	(591,502)	(4,573,445)	(2,569,644)	(4,621,833)
Loss on Consolidation of Alset Capital Acquisition Corp.				(21,657,036)
Other Expense	(223,911)		(262,481)
Other Income	161,501	717,951	370,855	1,808,489
Total Other Income (Expense), Net	2,433,020	(14,903,980)	(954,752)	(28,060,334)
Net Income (Loss) Before Income Taxes	1,469,239	(16,980,884)	(6,994,516)	(27,117,472)
Income Tax Expense		(45,124)		(45,124)
Net Income (Loss)	1,469,239	(17,026,008)	(6,994,516)	(27,162,596)
Net Loss Attributable to Non-Controlling Interest	(247,124)	(1,014,423)	(702,109)	(1,485,275)
Net Income (Loss) Attributable to Common Stockholders	1,716,363	(16,011,585)	(6,292,407)	(25,677,321)
Other Comprehensive Income (Loss)
Foreign Currency Translation Adjustment	4,221,505	(1,852,698)	1,805,678	(2,940,640)
Total Comprehensive Income (Loss)	5,690,744	(18,878,706)	(5,188,838)	(30,103,236)
Less Comprehensive Income (Loss) Attributable to Non-controlling Interests	366,478	(269,568)	(439,926)	(444,726)
Total Comprehensive Income (Loss) Attributable to Common Shareholders	$ 5,324,266	$ (18,609,138)	$ (4,748,912)	$ (29,658,510)
Net Income (Loss) Per Share - Basic	$ 0.19	$ (1.73)	$ (0.68)	$ (2.86)
Net Income (Loss) Per Share - Diluted	$ 0.19	$ (1.73)	$ (0.68)	$ (2.86)
Weighted Average Common Shares Outstanding - Basic	9,235,119	9,235,119	9,235,119	8,976,634
Weighted Average Common Shares Outstanding - Diluted	9,235,119	9,235,119	9,235,119	8,976,634
Nonrelated Party [Member]
Other Income (Expense)
Interest Income	$ 61,326	$ 97,996	$ 404,481	$ 229,662
Unrealized Gain (Loss) on Securities Investment	224,773	(193,991)	648,726	6,349,738
Related Party [Member]
Other Income (Expense)
Interest Income	8,890		82,126
Unrealized Gain (Loss) on Securities Investment	6,809,719	(10,548,684)	2,796,660	560,467
Rental [Member]
Revenue
Total Revenue	724,699	705,334	2,150,204	2,030,112
Property [Member]
Revenue
Total Revenue	3,815,000	6,300	8,847,500	18,197,250
Biohealth [Member]
Revenue
Total Revenue				12,786
Other [Member]
Revenue
Total Revenue	$ 421,012	$ 278,565	$ 1,176,260	$ 830,835